[go: up one dir, main page]

DZ2642A1 - Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ. - Google Patents

Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.

Info

Publication number
DZ2642A1
DZ2642A1 DZ980252A DZ980252A DZ2642A1 DZ 2642 A1 DZ2642 A1 DZ 2642A1 DZ 980252 A DZ980252 A DZ 980252A DZ 980252 A DZ980252 A DZ 980252A DZ 2642 A1 DZ2642 A1 DZ 2642A1
Authority
DZ
Algeria
Prior art keywords
spiroäisobenzufuran
piperidineü
butylü
3ylü
fluorphenyl
Prior art date
Application number
DZ980252A
Other languages
English (en)
Inventor
Niels Mark
Heidi Lopez De Diego
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DZ2642A1 publication Critical patent/DZ2642A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ980252A 1997-11-07 1998-11-04 Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ. DZ2642A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK126797 1997-11-07

Publications (1)

Publication Number Publication Date
DZ2642A1 true DZ2642A1 (fr) 2004-12-28

Family

ID=8102935

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980252A DZ2642A1 (fr) 1997-11-07 1998-11-04 Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.

Country Status (38)

Country Link
US (2) US6844352B2 (fr)
EP (1) EP1044202B1 (fr)
JP (1) JP3605358B2 (fr)
KR (1) KR100399274B1 (fr)
CN (1) CN1105115C (fr)
AR (1) AR023010A1 (fr)
AT (1) ATE288918T1 (fr)
AU (1) AU749094B2 (fr)
BG (1) BG64906B1 (fr)
BR (1) BR9813949A (fr)
CA (1) CA2308745C (fr)
CZ (1) CZ288666B6 (fr)
DE (1) DE69828999T2 (fr)
DZ (1) DZ2642A1 (fr)
EA (1) EA002092B1 (fr)
EG (1) EG23791A (fr)
ES (1) ES2234162T3 (fr)
HR (1) HRP20000261B1 (fr)
HU (1) HUP0100991A3 (fr)
ID (1) ID25776A (fr)
IL (1) IL135723A (fr)
IS (1) IS2342B (fr)
JO (1) JO2052B1 (fr)
MA (1) MA25585A1 (fr)
NO (1) NO325920B1 (fr)
NZ (1) NZ504065A (fr)
PE (1) PE130299A1 (fr)
PL (1) PL190538B1 (fr)
PT (1) PT1044202E (fr)
RS (1) RS49777B (fr)
SK (1) SK285245B6 (fr)
TN (1) TNSN98201A1 (fr)
TR (1) TR200001267T2 (fr)
TW (1) TW483894B (fr)
UA (1) UA64769C2 (fr)
UY (1) UY25236A1 (fr)
WO (1) WO1999024436A1 (fr)
ZA (1) ZA9810116B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
AU2003263155A1 (en) * 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
US7863272B2 (en) 2003-06-12 2011-01-04 M's Science Corporation Sigma ligands for neuronal regeneration and functional recovery
WO2007012319A1 (fr) * 2005-07-29 2007-02-01 Sigma-Aldrich Production Gmbh Melanges lc/ms contenant des additifs ionisants
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド 神経発生のgaba受容体媒介調節
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (fr) * 2006-05-09 2007-11-22 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2009002496A (es) * 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
IL135723A (en) 2005-11-20
JP2001522852A (ja) 2001-11-20
RS49777B (sr) 2008-06-05
EA200000502A1 (ru) 2000-10-30
JO2052B1 (en) 1999-05-15
DE69828999D1 (de) 2005-03-17
KR20010031791A (ko) 2001-04-16
ID25776A (id) 2000-11-02
EP1044202B1 (fr) 2005-02-09
KR100399274B1 (ko) 2003-09-26
HRP20000261B1 (en) 2009-04-30
HUP0100991A3 (en) 2003-03-28
UY25236A1 (es) 2000-12-29
CN1105115C (zh) 2003-04-09
CN1278823A (zh) 2001-01-03
DE69828999T2 (de) 2005-07-21
SK6462000A3 (en) 2000-10-09
CZ288666B6 (cs) 2001-08-15
HRP20000261A2 (en) 2001-04-30
EP1044202A1 (fr) 2000-10-18
US6844352B2 (en) 2005-01-18
YU23500A (sh) 2003-12-31
PL190538B1 (pl) 2005-12-30
TW483894B (en) 2002-04-21
ATE288918T1 (de) 2005-02-15
EA002092B1 (ru) 2001-12-24
PT1044202E (pt) 2005-04-29
ES2234162T3 (es) 2005-06-16
IS5460A (is) 2000-04-18
TR200001267T2 (tr) 2000-09-21
UA64769C2 (uk) 2004-03-15
IS2342B (is) 2008-02-15
BR9813949A (pt) 2000-09-26
NO20002188L (no) 2000-06-14
BG64906B1 (bg) 2006-08-31
EG23791A (en) 2007-08-13
TNSN98201A1 (fr) 2005-03-15
AU1022699A (en) 1999-05-31
PL340220A1 (en) 2001-01-15
SK285245B6 (sk) 2006-09-07
ZA9810116B (en) 1999-05-07
IL135723A0 (en) 2001-05-20
MA25585A1 (fr) 2002-12-31
CA2308745A1 (fr) 1999-05-20
AU749094B2 (en) 2002-06-20
BG104485A (en) 2001-01-31
PE130299A1 (es) 1999-12-16
NZ504065A (en) 2002-05-31
WO1999024436A1 (fr) 1999-05-20
HUP0100991A2 (hu) 2001-09-28
JP3605358B2 (ja) 2004-12-22
NO325920B1 (no) 2008-08-18
CZ20001663A3 (cs) 2000-10-11
HK1034075A1 (en) 2001-10-12
CA2308745C (fr) 2004-01-20
NO20002188D0 (no) 2000-04-27
US20050171135A1 (en) 2005-08-04
US20030055074A1 (en) 2003-03-20
AR023010A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
SV1996000005A (es) Quinazolinonas bisustituidas en 2,8
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
TR199800444A3 (tr) Hipolipidemik 1,4-benzotiazepin-1,1-diyoksitler.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
PT901487E (pt) 4(3h)-quinazolinonas 2,3,6-trissubstituidas
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
TR199800815A3 (tr) Sülfonilaminokarbonasitler.
TR199601002A1 (tr) 2-Okzo- ve 2-thio-1, 2-dihidrokinolinil-oksazolidinonlar.
TR28098A (tr) 1,2,4-okzadiazol türevleri.
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DZ2642A1 (fr) Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
CY2425B1 (en) 2,4-Diaminopyrimidine derivatives.
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
ZA982327B (en) Substituted 2-benz(O)ylpyridines.
DE69906149D1 (de) 4,5-azolo-oxindole
TR199501562A2 (tr) Tiyenopiridon'lar.
ZA986160B (en) 2,4,4-trisubstituted-1,3-dioxolone antifungals.
ID26368A (id) Turunan-turunan 2 deoksi higromisin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
ZA984592B (en) Herbicidal 3,5-difluoropyridines.